No Barrier
Instant AI Medical Interpreting at the Point of Care
Health Tech & Life Sciences
Private
Company Overview
Snapshot
Founded in June 2025 by Eyal Heldenberg and Moe Abramovitch, No Barrier operates with 1–10 employees. The company has secured funding across one round from two investors, including Esplanade Healthcare Ventures and A-Squared Ventures.
Business overview
No Barrier develops an AI medical interpreter platform designed for hospitals, clinics, and healthcare networks. Its core technology provides real-time speech-to-speech interpretation, enabling instant communication between healthcare providers and limited English proficiency (LEP) patients. The platform is HIPAA compliant, built for clinical accuracy, and includes safety controls such as easy escalation to human interpreters when necessary.
Log in to access full profile ›Company Intelligence Q&A
- When was No Barrier founded?
- No Barrier was founded in June 2025 by co-founders Eyal Heldenberg and Moe Abramovitch.
- What is No Barrier's primary focus?
- No Barrier focuses on providing instant AI medical interpreting at the point of care, facilitating real-time speech-to-speech interpretation for healthcare providers and limited English proficiency patients.
- What is the company's employee count?
- No Barrier currently operates with 1–10 employees.
- Which investors participated in No Barrier's funding round?
- In June 2025, No Barrier secured funding from Esplanade Healthcare Ventures and A-Squared Ventures.
- What technology does No Barrier utilize?
- No Barrier leverages Artificial Intelligence to power its real-time speech-to-speech medical interpretation platform.